Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Federal Trade Commission
Cerilliant
UBS
Covington
Merck
Citi
McKinsey

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208437

« Back to Dashboard

NDA 208437 describes LONHALA MAGNAIR KIT, which is a drug marketed by Sunovion Resp and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug. Additional details are available on the LONHALA MAGNAIR KIT profile page.

The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 208437
Tradename:LONHALA MAGNAIR KIT
Applicant:Sunovion Resp
Ingredient:glycopyrrolate
Patents:9
Formulation / Manufacturing:see details
Pharmacology for NDA: 208437
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for 208437
Suppliers and Packaging for NDA: 208437
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437 NDA Sunovion Pharmaceuticals Inc. 63402-201 63402-201-00 1 CARTON in 1 KIT (63402-201-00) > 30 POUCH in 1 CARTON > 2 VIAL, SINGLE-DOSE in 1 POUCH > 1 mL in 1 VIAL, SINGLE-DOSE
LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437 NDA Sunovion Pharmaceuticals Inc. 63402-301 63402-301-01 1 CARTON in 1 KIT (63402-301-01) > 30 POUCH in 1 CARTON > 2 VIAL, SINGLE-DOSE in 1 POUCH > 1 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATIONStrength25MCG/ML
Approval Date:Dec 5, 2017TE:RLD:Yes
Regulatory Exclusivity Expiration:Dec 5, 2020
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ Try a Free TrialPatent Expiration:Oct 27, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Sep 6, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Covington
Mallinckrodt
Moodys
Federal Trade Commission
QuintilesIMS
Fuji
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.